Evidence map›Paper›PMID 27745636›Full record

ArticleJournal of the American Academy of Dermatology2016

Family history of cutaneous and noncutaneous malignancies in relation to the risk of keratinocyte carcinoma coupled with another type of cancer: A case-control study.

James Small, Catherine Flanagan, Kent Armeson, David Perry, Richard Marchell, Bruce Thiers, Anthony J Alberg

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of the American Academy of Dermatology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

James SmallDepartment of Public Health Sciences, Medical University of South Carolina, Charleston.
Catherine FlanaganHollings Cancer Center, Medical University of South Carolina, Charleston.
Kent ArmesonDepartment of Public Health Sciences, Medical University of South Carolina, Charleston; Hollings Cancer Center, Medical University of South Carolina, Charleston.
David PerryDepartment of Dermatology, Medical University of South Carolina, Charleston.
Richard MarchellDepartment of Dermatology, Medical University of South Carolina, Charleston.
Bruce ThiersDepartment of Dermatology, Medical University of South Carolina, Charleston.
Anthony J AlbergDepartment of Public Health Sciences, Medical University of South Carolina, Charleston; Hollings Cancer Center, Medical University of South Carolina, Charleston. Electronic address: alberg@musc.edu.

Funding

Translational Science Laboratory Shared ResourceP30CA138313 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI RAYMOND N. DUBOIS · 2009 to 2026
$42.7M
South Carolina Clinical & Translational Research Institute (SCTR)UL1TR001450 · NCATS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BRADY, KATHLEEN T., FLUME, PATRICK A · 2015 to 2024
$41.1M
South Carolina Clinical & Translational Research Institute (SCTR)UL1TR000062 · NCATS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BRADY, KATHLEEN T. · 2012 to 2014
$9.4M
NCATS NIH HHS UL1 TR000062NCATS NIH HHS UL1 TR001450NCI NIH HHS P30 CA138313
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AgedCarcinomaCase-Control StudiesConfounding Factors, EpidemiologicFemaleHumansKeratinocytesMaleMiddle AgedNeoplasms, Multiple PrimaryRisk FactorsSkin NeoplasmsWhite People

Identifiers

PMID27745636
PMCPMC5119530

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.